ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
67 hedge funds and large institutions have $86.2M invested in Antares Pharma, Inc. in 2016 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
30% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 23
Holders
67
Holding in Top 10
3
Calls
$105K
Puts
–
Top Buyers
| 1 | +$1.02M | |
| 2 | +$814K | |
| 3 | +$613K | |
| 4 |
KCM
Kingdon Capital Management
New York
|
+$584K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$501K |
Top Sellers
| 1 | -$5.26M | |
| 2 | -$2.84M | |
| 3 | -$1.11M | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$607K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$565K |